Please provide your email address to receive an email when new articles are posted on . The WaveWriter is approved to treat low back and leg pain in patients without prior back surgery. The system ...

LAS VEGAS, Nev.--(BUSINESS WIRE)--During the scientific sessions at the 16 th Annual NANS Conference, Dr. Liong Liem, Anesthesiologist at Sint Antonius Ziekenhuis in the Netherlands and member of the ...

Empower BP is a landmark global pivotal study evaluating the safety and effectivenessof the implantable ARC-IM® Systemto address blood pressure ...

Spinal cord stimulators deliver mild electrical impulses to the spinal cord, which can disrupt pain signals before they reach the brain. As patients go about their daily lives, certain movements may ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Prospera, a spinal cord stimulation system to treat those with chronic intractable pain in ...

Spinal cord stimulators have been used since the 1960s, and the first FDA approval for one of the devices arrived in 1989—all with a focus on treating various forms of chronic pain. In more recent ...

Protégé upgradeable neurostimulator from St. Jude Medical is the world’s smallest, longest-lasting rechargeable device to treat chronic pain SCS system is designed to be non-invasively upgraded to ...

Senza® HFX iQ™ is the First and Only SCS System that Uses Artificial Intelligence to Optimize and Maintain Pain Relief Using Each Patient's Response REDWOOD CITY, Calif., March 7, 2023 /PRNewswire/ -- ...

After racking up more than 30 years’ worth of experience in treating chronic pain, spinal cord stimulators have recently begun to expand their remit. Even as the devices continue to tack on new ...

Nevro yesterday announced that the FDA has granted approval for a study evaluating its high-frequency spinal cord stimulation system for the treatment of chronic pain. The device company’s Senza ...